Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:40 AM
Ignite Modification Date:
2025-12-25 @ 12:40 AM
NCT ID:
NCT00808067
Eligibility Criteria:
Inclusion criteria:
Participation in RE-LY, requires long term anticoagulation, provides written informed consent
Exclusion criteria:
Permanent discontinuation of dabigatran during RE-LY
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00808067
Study Brief:
Protocol Section:
NCT00808067